TT, what really doesn’t make much sense is why would the company use CR money in its recent raise to fund manufacturing capacity at its plant if the ultimate plan is to sell the company off to a bidder?
Wouldn’t you agree that is somewhat inconsistent? Maybe the idea is to increase manufacturing capacity to align with increased sales and increased trial use. Ramping up production capacity is more a medium to long term strategy rather than a shorter term flip objective.
Ann: Two more PANCOSIL Trial treatments using OncoSil device, page-82
-
- There are more pages in this discussion • 158 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
-0.001(16.7%) |
Mkt cap ! $16.66M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $2.867K | 573.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 4186862 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 15328756 | 23 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| OSL (ASX) Chart |